Quantitative assessment of pericardial delayed hyperenhancement helps identify patients with ongoing recurrences of pericarditis

Objectives Recurrences of pericarditis (RP) are often difficult to diagnose due to lack of clinical signs and symptoms during subsequent episodes. We aimed to investigate the value of quantitative assessment of pericardial delayed hyperenhancement (DHE) in diagnosing ongoing recurrences of pericarditis. Methods Quantitative DHE was measured in 200 patients with established diagnosis of RP using cardiac MRI. Conventional clinical criteria for diagnosis of pericarditis were ≥2 of the following: chest pain, pericardial rub, ECG changes and new or worsening pericardial effusion. Results A total of 67 (34%) patients were identified as having ongoing episode of recurrence at the time of DHE measurements. In multivariable analysis, chest pain (OR: 10.9, p<0.001) and higher DHE (OR: 1.32, p<0.001) were associated with ongoing recurrence of RP. Addition of DHE to conventional clinical criteria significantly increased the ability to diagnose ongoing recurrence (net reclassification improvement (NRI): 0.80, p<0.001; integrated discrimination improvement (IDI): 0.12, p<0.001). Among 150 patients with history of RP who presented with chest pain, higher DHE was still independently associated with ongoing recurrence (OR: 1.28, p<0.001), showed incremental value over clinical criteria (NRI: 0.76, p<0.001; IDI: 0.13, p<0.001) and demonstrated a sensitivity of 70% and specificity of 74%. Conclusion Among patients with RP, quantitative DHE provided incremental information to diagnose ongoing recurrences over conventional clinical criteria of pericarditis. Quantitative DHE demonstrated acceptable test characteristics to diagnose ongoing recurrence even in RP patients presenting with chest pain.

[1]  B. Tamarappoo,et al.  Quantitative Pericardial Delayed Hyperenhancement Informs Clinical Course in Recurrent Pericarditis. , 2017, JACC. Cardiovascular imaging.

[2]  A. Klein,et al.  Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment. , 2016, Journal of the American College of Cardiology.

[3]  A. Klein,et al.  Pericardial enhancement using multimodality imaging in a rare auto-inflammatory disorder. , 2016, International journal of cardiology.

[4]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the diagnosis and management of pericardial diseases , 2015, European heart journal.

[5]  S. Flamm,et al.  Quantitative Assessment of Pericardial Delayed Hyperenhancement Predicts Clinical Improvement in Patients With Constrictive Pericarditis Treated With Anti-Inflammatory Therapy , 2015, Circulation. Cardiovascular imaging.

[6]  P. Rajiah,et al.  Cardiac MR imaging in constrictive pericarditis: multiparametric assessment in patients with surgically proven constriction , 2015, The International Journal of Cardiovascular Imaging.

[7]  Y. Adler,et al.  Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial , 2014, The Lancet.

[8]  Scott D Flamm,et al.  Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update , 2013, Journal of Cardiovascular Magnetic Resonance.

[9]  Richard D. White,et al.  American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  J. Bogaert,et al.  Pericardial disease: value of CT and MR imaging. , 2013, Radiology.

[11]  Scott D Flamm,et al.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing , 2013, Journal of Cardiovascular Magnetic Resonance.

[12]  H. Schaff,et al.  Pericardiectomy vs medical management in patients with relapsing pericarditis. , 2012, Mayo Clinic proceedings.

[13]  S. Flamm,et al.  Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. , 2011, JACC. Cardiovascular imaging.

[14]  Matthew W. Martinez,et al.  Cardiac Magnetic Resonance Imaging Pericardial Late Gadolinium Enhancement and Elevated Inflammatory Markers Can Predict the Reversibility of Constrictive Pericarditis After Antiinflammatory Medical Therapy: A Pilot Study , 2011, Circulation.

[15]  S. Dymarkowski,et al.  Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results , 2006, European Radiology.

[16]  J. Soler‐Soler,et al.  Relapsing pericarditis , 2004, Heart.

[17]  J. Karjalainen,et al.  Recurrent pericarditis in children and adolescents: report of 15 cases. , 2003, Journal of the American College of Cardiology.

[18]  N. Fowler,et al.  Recurrent acute pericarditis: follow-up study of 31 patients. , 1986, Journal of the American College of Cardiology.

[19]  F. Gaita,et al.  Recurrent Pericarditis. , 2017, Progress in cardiovascular diseases.

[20]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.